Analysts expect over 2018 rising revenue Abbott

Tomorrow the American company Abbott will publish its past quarter's results. For this year Abbott 's revenue will be around 30,74 billion USD. This is according to the average of the analysts' estimates. This is quite more than 2017's revenue of 27,39 billion USD.

Historical revenues and results Abbott plus estimates 2018

stock analysis

The analysts expect for 2018 a net profit of 5,11 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 2,89 USD. Based on this the price/earnings-ratio is 23,77.

Analysts expect a dividend of 1,13 USD per share. The dividend yield is then 1,64 percent. The average dividend yield of the pharmaceutical companies is a moderate 0,5 percent.

Based on the current number of outstanding shares Abbott 's market capitalization is 101,19 billion USD. The Abbott stock was the past 12 months quite unstable. Since last October the stock is even 28 percent higher. This year the stock price moved between 54 and 74 dollar. Since 2008 the stock price is almost 159 percent higher.

At 17.30 the stock trades 2,33 percent higher at 68,7 USD.

Historical stock prices Abbott

stock analysis abbott

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.